Justin Byers is the founder and CEO of Axio BioPharma. He holds a BS in biochemistry and molecular biology from Illinois State University and has held leadership roles at Illumina, Danaher, and ...
A study conducted by researchers at Ohio State University and the New York University Grossman School of Medicine in the USA, has revealed that optimization of codon for bacterial expression causes ...
DNA vaccines require a considerable enhancement of immunogenicity. Here, we optimized a prototype DNA vaccine against drug-resistant HIV-1 based on a weak Th2-immunogen, HIV-1 reverse transcriptase ...
Translational proof-of-concept studies for gene therapeutics often match the payload gene sequence to the preclinical animal model as this avoids immune responses that could compromise drug efficacy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results